Cincera Therapeutics Pty Ltd
Cincera Therapeutics is advancing modern approaches to the treatment of fibrotic diseases, developing a novel drug class that greatly improves the efficacy of fibrosis therapies. Enabling reductions in fibrosis at far smaller doses than current benchmark compounds, Cincera’s therapies could have potentially life-saving impacts for sufferers of fibrosis and transform the treatment landscape of fibrotic diseases.
Year established: 2021
Lead Researcher & Founder: Bernie Flynn
Lead researcher: Stuart Pitson (UniSA)
Website: cinceratx.com